West Nile Virus (WNV) is the one of most widespread arboviruses 17 worldwide. WNV exists in a bird-mosquito transmission cycle where passerine birds 18 act as the primary reservoir host. As a public health concern, the mammalian 19 immune response to WNV has been studied in detail. Little, however, is known 20 about the avian immune response to WNV. Avian taxa show variable susceptibility 21
to WNV and what drives this variation is unknown. Thus, to study the immune 22 response to WNV in birds, we experimentally infected captive zebra finches 23 (Taeniopygia guttata). Zebra finches provide a useful model, as like many natural 24 avian hosts they are moderately susceptible to WNV and thus provide sufficient 25 viremia to infect mosquitoes. We performed splenic RNAseq during peak viremia to 26 provide an overview of the transcriptional response. In general, we find strong 27 parallels with the mammalian immune response to WNV, including up-regulation of 28 five genes in the Rig-I-like receptor signaling pathway, and offer insights into avian 29 specific responses. Together with complementary immunological assays, we 30 provide a model of the avian immune response to WNV and set the stage for future 31 comparative studies among variably susceptible populations and species. 32 33
Introduction: 34
West Nile virus (WNV) is a single-stranded RNA flavivirus that exists in an 35 avian-mosquito transmission cycle, where birds (typically Passeriformes) act as the 36 primary amplification hosts. In addition to birds, nearly 30 other non-avian vertebrate 37 species have been documented as hosts (1). Although many WNV-infected hosts are 38 asymptomatic, WNV infection can cause severe meningitis or encephalitis in those that 39 are highly susceptible. Avian species for the most part exhibit low to moderate 40 susceptibility. That is, individuals become infected and develop sufficient viremia for 41 transmission via mosquito blood meal, but the hosts recover and avoid significant 42 mortality, reviewed in (2). First described in 1937, WNV has not resulted in widespread 43 avian decline throughout its historical range (3), perhaps due to host-parasite coevolution. 44
However, the emergence of WNV in North America in 1999 has negatively impacted a 45 wide range of populations (4, 5) . Surveys of North American wild birds have shown a 46 variety of competent WNV hosts, with varying degrees of susceptibility, morbidity, and 47 pathogenicity (2). American robins (Turdus migratorius) appear to be the main host in 48 spreading WNV infection in North America (6), but infection appears most detrimental to 49 members of Family Corvidae (7) . Despite great variation in susceptibility, the 50 mechanisms underlying this variation are primarily unknown (2). 51
52
Largely due to interest in human health implications, most work describing the 53 host immune response to WNV infection has been performed in mammalian systems (8) . 54
From these studies, we know that in mammals, both the innate and adaptive arms are 55 critical for virus detection and clearance (9,10). Within the innate immune response, the 56 retinoic acid-inducible gene 1(Rig-I)-like receptor (RLR) pathway appears to play a key 57 role in viral clearance. This pathway recognizes viral products and initiates type I 58 interferon expression (11). Mice lacking the viral recognition RLR genes in this pathway, 59
DDx58 (Rig-I) and IFIH1 (MDA5), become highly susceptible to WNV infection (12). In 60 the adaptive immune system, a broad range of components appear to play important roles 61 in mounting a response, including antibody and CD4+ and CD8+ T cells (9, 13, 14) . 62
Interestingly, major histocompatibility complex (MHC) class I genes are up-regulated 63 post-infection (15, 16) . Viruses typically evade MHC class I detection (17, 18) , as MHC 64 class I molecules bind and present viral peptides to CD8+ T cells. However, the purpose 65 of WNV induced MHC expression is unclear. 66
67
While the mammalian immune response to WNV infection has been extensively 68 studied, the avian immune response remains mostly unknown. Of the studies in birds, 69 many involve experimentally infecting wild caught birds, reviewed in (2), or domestic 70 chickens (Gallus gallus) (19) . These studies primarily focus on viral detection, tissue 71 tropism, antibody production, or lymphocyte counts (2, 19, 20) . Little is known about the 72 molecular mechanisms driving the immune response to WNV infection, but see (21) . 73 Furthermore, current avian WNV studies suffer many challenges. Wild caught birds may 74 be co-infected with other parasites (e.g. avian malaria) and are difficult to maintain in 75 captivity for experimental infection studies. Chickens, although an avian model species, 76 are highly resistant to WNV infection (22), uncommon hosts, and therefore are not ideal 77 to describe the avian immune response to WNV infection. Passeriformes and Galliformes 78 are also highly divergent bird lineages, with distinctive immune gene repertoires and 79 architecture (23). 80
81
As passerine birds are the main hosts for WNV, we have sought to develop a 82 passerine model to study the impacts of WNV infection on a taxonomically appropriate 83 host (24). We have recently shown that zebra finches, Taeniopygia guttata, are 84 moderately susceptible hosts for WNV (25) . That is, WNV rapidly disseminates to a 85 variety of tissues and is detectable in most samples by four days post-inoculation (dpi). 86
Despite rapid development of sufficient viremia for arthropod transmission, zebra finches 87 develop anti-WNV anitbodies, clear WNV by 14dpi, and avoid significant mortality (25) . 88
This moderate disease susceptibility is similar to what is observed in many natural WNV 89 hosts. Zebra finches are also an established biomedical model system with a suite of 90 genetic and genomic tools available (26) . 91
92
In this study, we experimentally infected zebra finches and performed splenic 93
RNAseq to describe their transcriptional response over the time course of infection. In 94 doing so, we characterize the zebra finch immune response to WNV infection, explore 95 expression of the avian RLR pathway in response to WNV, gain insights into the avian 96 immune response to this widespread infectious disease, and uncover conserved 97 evolutionary responses in avian and mammalian systems. 98
99
Results 100
Experimental infection 101
We challenged six individuals with with 10 5 plaque forming units (PFU) WNV 102 and sequenced RNA (Illumina RNAseq) isolated from spleens, an organ critical to the 103 avian immune response. Three birds served as procedural controls and on day 0 were 104 injected subcutaneously with 100 µL of BA1 media, as previously described (27) . 105
Peak viremia occurrs at 4.6 ±1.7 dpi as quantified via RT-PCR (25) and thus, we 106 characterized the transcriptional response leading to (2dpi, n=3) and at peak viral load 107 (4dpi, n=3) in the present study. WNV RNA was detected by culture in lung and kidney 108 RNA pools of 2 out of 3 birds sampled at day 2, and all 3 birds sampled at 4dpi. These 109 findings were verified by semi-quantitative RT-PCR. Because WNV is rarely detected in 110 spleen by 2dpi, but all birds previously inoculated at 10 5 PFU developed WNV antibodies 111
[25] we treated all six birds inoculated with WNV as being infected. 112 113
Sequencing results & read mapping 114
We obtained 18-30 million paired-end, 100bp reads for each sample and removed 115 0.57-1.24% of the total bases after adapter trimming ( Supplementary Table S1 ). On 116 average, 79.0-80.8% total trimmed reads mapped to the zebra finch reference genome 117
( Supplementary Table S2 ), corresponding to 18,618 Ensembl gene IDs. Of these, 14,114 118 genes averaged at least five mapped reads across all samples and were utilized for 119 differential expression (DE) analyses. 120 121
Sample clustering & differential expression 122
We tested for DE two ways: as pairwise comparisons between treatments to 123 identify specific genes with DEseq2 (28) and as a time-course grouping genes into 124 expression paths with EBSeqHMM (29). To visualize patterns of expression variation 125 among samples, we conducted principal component analysis (PCA) and distance-based 126 clustering (Supplemental Figures S1 & S2 ). The first three principal components 127 explained 93.04% of the variance in gene expression, but none of the PCs were 128 significantly correlated with treatment (ANOVA, PC1: p = 0.288, PC2: p = 0.956, PC3: p 129 = 0.202). Although this finding suggests that much of the expression variation was 130 independent of the experimental treatment, pairwise comparisons revealed genes that 131 were DE between treatments. 132 133 When comparing Control vs. 2dpi, we found 161 differentially expressed genes 134 (adjusted p < 0.10, average log 2 fold-change (FC) = 1.74). This gene list includes several 135 immune related genes associated with the innate (e.g. IL18) and adaptive (e.g. MHC IIB) 136
immune system (Table 1, Figure 1 ). Sixty-five genes were differentially expressed 137 between Control and 4dpi (average log 2 FC = 1.61), also with several immune relevant 138 genes including five genes in the RLR pathway (Table 1, Figure 2 , Figure 3 ). Lastly, we 139 observed 44 DE genes between 2dpi vs. 4dpi individuals (average log 2 FC = 1.56). Three 140 of these have described functions in immunity. The complete list of DEseq2 DE genes 141 (adjusted p < 0.10) across all comparisons can be found in Supplementary Table S3 and 142 immune relevant DE genes are listed in Table 1 along with their gene name, log 2 fold 143 change, padj value, and comparison to mammalian studies. We also combined 2dpi and 144 4dpi cohorts and compared with control, but due to high variation in gene expression 145 between days 2 and 4 dpi, we only found 16 DE genes (average log 2 FC = 1.64) between 146
Control and Infected cohorts, one of which was associated with immunity. 147
148
When analyzed for DE as a time course in EBSeqHMM, 686 genes showed 149 evidence of differential expression (posterior probability > 0.99, FDR < 0.01). Most DE 150 genes (n = 561) were suppressed following infection ("Down-Down") or varied between 151 conditions. Seventy-five genes were "Up-Down", 49 were "Down-Up" and 1 was "Up-152
Up". As expected, we found overlap of several immune genes between the two analyses. 153
For example, IL18, APOD and IFITM10 are "Up-Down" ( Supplementary Table S5 ) and 154 this trend is reflected in the DEseq2 Control vs 2dpi analysis ( Figure 1) . 155 156 Functional annotation of differentially expressed genes 157
To place differentially expressed genes into groups based on their biological 158 function, we performed a gene ontology (GO) analysis using the GOfinch tool (30). As 159 above, we conducted GO analyses based on multiple pairwise analyses of gene 160 expression. The strongest evidence of functional enrichment was observed in the contrast 161 of Control vs. 4dpi. This list of 65 differentially expressed genes showed functional 162 enrichment of 55 GO terms (Fisher's Exact Test, FDR p < 0.05 (Benjamini Hochberg 163 method [31] )). It is in this contrast where the immune response manifests itself most 164 strongly, with a large list of immune-related categories ( Supplementary Table S4 ) and a 165 broad range of immune functioning genes differentially expressed (n=14 , Tables 1 & 2) . 166
When comparing genes differentially expressed between Control and 2dpi, only one GO 167 category was strongly enriched ("integral to membrane", expected = 15, observed = 35, p 168 = 0.00065). In this contrast we also observed several slightly enriched immune related 169 GO categories such as "inflammatory response" and "negative regulation of T cell 170 migration" but these fall outside of our significance threshold ( Supplementary Table S4 ) 171 and reflect only few genes (e.g. APOD and IL18) that were DE in the Control vs. 2dpi 172 analysis. A set of 57 enriched GO categories describe genes DE between 2 and 4dpi. 173
Although some of these involved T and B cell regulation, these categories were also only 174
represented by a single gene each (ADA) ( Supplementary Table S5 ). 181
Interestingly, Up-Down GO categories had the strongest representation of immune 182 related GO terms, including "cytokine receptor activity" (expected = 0, observed = 3 p = 183 0.015) and "positive regulation of interferon-gamma production" (expected = 0, observed 184 = 2, p = 0.028). However, we also observed a strong immune signature among Down-185 Down Genes (GO Term "Immune Response", expected = 3, observed = 11, p = 0.013), 186 which represents several innate immune genes including three complement genes and 187 interferon gamma. Twelve categories were significantly enriched among "Down-Up" 188 genes, including "double-stranded RNA binding" (expected = 0, observed = 2, adjusted p 189 = 0.049). One of the observed genes in this category is OASL, which has been 190 demonstrated to have antiviral activity towards WNV in chickens (21). Lastly, as in the 191
DEseq2-based analysis, we also detected a strong enrichment signature of membrane 192 proteins. Genes annotated as "integral to membrane" were highly enriched among those 193
showing an Up-Down pattern (expected = 6, observed =14, adjusted p < 0.028, 194 Supplementary Table S5 ). Combined, we find broad overlap in GO representation 195 between the EBseqHMM and DEseq2 approaches. Figure S3 ). We detect expression of 36/37 genes in the 205 pathway, many of which are also up-regulated, though not always significantly. 206
207
De novo transcriptome analysis 208
To reveal any genes responding to infection missed by our genome based 209 analysis, we created a reference transcriptome with Trinity v2.1.1 (35) and annotated 210 against the NCBI non-redundant database with DIAMOND, a BLASTx-like aligner (37). 211
Our de novo transcriptome assembly resulted in 393,408 Trinity transcripts. We 212 visualized our annotated transcriptome with MEGAN (38), which places genes into 213 KEGG pathways. In doing so, we confirmed many expression results from the genome-214 based approach and importantly, this analysis revealed expression of two transcripts with 215 homology to interferon alpha, which was absent (but annotated) in the genome based 216 analysis described above. Combined, our genome-based and reference-free approaches 217 detect regulation of the complete RLR pathway in zebra finches. 218 219
Discussion 220
We have characterized the zebra finch transcriptional response to WNV infection. 221
Overall, we find that as in mammalian systems, components of both the adaptive and 222 innate immune pathways are activated following infection. While WNV is primarily an 223 avian specific infectious disease, most work describing the host immune response to 224 infection has been performed in mammals. Despite genomic, physiological and 225 evolutionary differences between birds and mammals, the host immune response shows 226 broad similarity between taxa (Table 1) . 227
228
We were particularly interested in the role of the innate RLR pathway. This 229 pathway mounts an antiviral innate immune response and is critical for WNV detection 230 and clearance in mammals (12). By combining genome and transcriptome-based 231 approaches, we show here that the RLR pathway in zebra finches is induced by WNV 232 infection, as gene expression is detected throughout the pathway. Furthermore, five genes 233 in this pathway are significantly up-regulated at 4dpi (Figure 3, Supplementary Figure  234 S3), including IFIH1 and DDx58 ( Figure 2B ), which encode molecules that recognize 235 WNV particles in mammals (39). This results in a corresponding over-representation of 236 genes in the RLR pathway GO categories (Table 2) . While no studies have investigated 237 the role of the RLR following WNV infection in birds, this pathway appears important 238 for avian influenza clearance in ducks (32-34), Buggy Creek virus clearance in house 239 sparrows (39), and likely for the broad avian antiviral immune response, including WNV. 240
241
We observed other parallels with mammals as well (Table 1) Figure 1 ). Unlike mammals, however, we found that MHC class I is not significantly DE 263 in any comparison. In mammals, upregulation of MHCI may not be adaptive for the host, 264 as upregulation may actually be a mechanism by which the virus evades Natural Killer 265 (NK) cell detection by the innate immune system (15). It has also been suggested that 266 MHC up-regulation is a byproduct of flavirus assembly (49). Interestingly, at 2dpi, 267
interleukin-18 (IL18) is significantly up-regulated (Table 1, Figure1A,B ). IL18 can 268 enhance NK cell activity (50) and is potentially a mechanism by which the immune 269 system can counteract WNV evasion strategies via NK cell activation, although further 270 testing is needed to quantify NK cell activity in zebra finches to support this hypothesis. 271 272 Despite many similarities, several immune genes differentially expressed in our 273 analyses have not been previously reported in the mammalian WNV literature or are 274 expressed differently in zebra finches (Table 1) . For example, at 2dpi, the 275 proinflammatory cytokine IL18 was significantly up-regulated in zebra finches ( Figure  276 1), contrasting a previous study in human cell lines, which show no difference in IL18 277 expression following WNV infection (50). Furthermore, interferon regulatory factor 6 278 (IRF6) was down-regulated at 2dpi, but up-regulated in human macrophages following 279 infection (43). Another significantly down-regulated gene at 2dpi, ubiquitin carboxyl-280 terminal hydrolase L1 (UCHL1), has been shown to suppress cellular innate immunity in 281 human cell lines infected with high-risk human papilloma virus (52). Down-regulation 282 restores functional pattern recognition receptor (PRR) pathways (e.g. RLR). The down-283 regulation of UCHL1 here thus is associated with the previously described regulation of 284 the PRR RLR pathway in this study (Table 1) . Lastly, interferon-induced protein with 285 tetratricopeptide repeats (IFIT) and interferon-inducible transmembrane proteins (IFITM) 286 gene families are known innate antiviral proteins and have been shown to restrict WNV 287 entry in human cells lines (47, 53) . Both IFIT5 and IFITM10 are up-regulated ( Figure  288 2A,C) in our study and yet, to our knowledge, neither have previously been implicated in 289 the host immune response to WNV. This potentially reveals an avian specific function of 290 IFIT5 and IFITM10. 291 292 Like many passerine birds infected in nature, zebra finches are moderately 293 susceptible to WNV, developing sufficient viremia to serve as competent hosts, but 294 generally resisting mortality due to infection (25) . While there are clear differences 295 among treatments in terms of differentially expressed genes (Table 1) , the weak effect of 296 treatment on overall expression profile (Supplemental Figure S1 & S2) . may be a 297 reflection of this moderate susceptibility. Most zebra finches are able to clear WNV 298 inflection by 14 dpi (25). In pairwise comparisons, there are between 16 and 161 299 differentially expressed genes, depending on the treatment comparison (Supplementary 300 Table S3 ). WNV infection intensity varies among tissues (20), but due to the spleen's 301 important role in the avian immune system (54,55), we expect these results to be 302 representative of the overall immune response. 303 304 Functional enrichment of several immune GO terms primarily appears in Up-305 Down path defined by EBseqHMM ( Supplementary Table S5 ), as many genes in the 306 immune system are up-regulated post-infection, as also seen in the DEseq2 analysis 307 (Table 1 , Figure 1, Figure 2) . In both the EBseqHMM and DEseq2 analyses, most of the 308 significant immune GO categories are innate immune responses, although adaptive 309 immune categories involved in B/T cell proliferation appear in both (Table 2 , 310 Supplementary Tables S4 & S5 ). Similar to the mammalian model, broad organismal 311 processes, encompassing the entire immune response, are represented in the zebra finch 312 response to WNV. 313
314
The zebra finch was the second bird to have its genome sequenced (26). However, 315 the zebra finch genome assembly and gene annotation remain incomplete. Immune genes 316 in particular are difficult to reconstruct in genomes due to their complex evolutionary 317 history (e.g. MHC, [23]). Our mapping results indicated that roughly 80% of our reads 318 mapped to the genome. While the unmapped 20% could contain poor quality reads or 319 non-avian sequences, it also represents zebra finch reads that could not be appropriately 320 mapped to the reference. Thus, we took a genome-independent approach and assembled a 321 de novo zebra finch transcriptome from our nine paired-end samples. Interestingly, RLR 322 induced interferon expression was not detected in the genome-based analysis. The 323 transcriptome analysis, however, revealed expression of two transcripts with homology to 324 interferon alpha, thus completing the pathway from virus detection to interferon 325 production. 326
327
We have begun to develop the zebra finch as an avian model for the host response 328 to WNV infection. We show here that the zebra finch immune response is largely 329 conserved with that seen in mammalian-based studies (Table 1) . Additionally, we 330 identify many components of the immune system that have not been previously 331 implicated in the host immune response to WNV. This potentially reveals an avian-332 specific immune response and highlights avenues for future research. Combined with our 333 recent immunological characterization (25), we have broadly described the immune 334 response of a moderately susceptible avian host for WNV. This sets the stage for future 335 comparative work to uncover the genetic basis of variable avian susceptibility to WNV 336 infection. 337
338
Methods 339
Experimental Setup 340
All animal use was approved by the USGS National Wildlife Health Center 341
Institutional Animal Care and Use Committee (IACUC Protocol: EP120521) and this 342 study was performed in accordance with USGS IACUC guidelines. The experimental 343 infection setup is described in detail in (25) . Briefly, nine female zebra finches were 344 randomly divided into three cohorts, one unchallenged and two challenged (n = 3 each). 345
Birds were challenged subcutaneously with 100ul BA1 media containing 10 5 plaque-346 forming units (PFU) of the 1999 American crow isolate of WNV (NWHC 16399-3) and 347 sacrificed at 2 and 4 dpi, corresponding to peak viremia. Uninfected individuals were 348 injected with 100ul BA1 media and sacrificed at 4dpi. WNV infection was confirmed by 349 RT-PCR, as previously described (26) conditions. Genes are then grouped into expression paths (i.e. "Up-Down", "Down-405
Down"), in which DE occurs when expression paths change between at least one adjacent 406 condition. For example, a gene up-regulated at both 2dpi relative to control and 4dpi 407 relative to 2dpi would be classified as "Up-Up". We included three time points, with 408 control individuals classified as t1, 2dpi as t2 and 4dpi as t3. Genes were considered DE 409 at posterior probability > 0.99 and FDR < 0.01. We chose a more stringent cutoff in this 410 analysis as EBseq can be liberal in classifying differential expression (65) and based on 411 visual inspection of expression profiles. Using genes identified as DE we performed 412 the GO analysis described above. 413
414
De novo transcriptome analysis 415
The use of Ensembl gene annotations for read counting restricts analyses to 416 previously annotated genes. To test for potential regulation in any unannotated genes, we 417 created a de novo transcriptome from our trimmed, paired-end reads using Trinity v2.0.6 418 (36). We used default Trinity parameters with the exception of server specific settings 419 (e.g. --max_memory 100G) and strand specificity (--SS_lib_type RF). To annotate our 420 transcriptome, we used the BLASTX-like aligner DIAMOND v0.7.11 (37), which utilizes 421 NCBI's non redundant database. We visualized results in MEGAN v5.10.6 (38), which 422 places transcripts into functional pathways (e.g. KEGG), facilitating comparisons to our 423 genome based analysis. 424 
